Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H Yong

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Statistics in Medicine|January 30, 2004
Growth velocity assessment in paediatric AIDS: smoothing, penalized quantile regression and the definition of growth failureV J Carey, F H Yong, L M Frenkel, et al.
AIDS (London, England)|August 26, 1998
Pediatric AIDS prognosis using somatic growth velocityV J Carey, F H Yong, L M Frenkel, et al.
AIDS Research and Human Retroviruses|April 20, 2000
Effect of food and pharmacokinetic variability on didanosine systemic exposure in HIV-infected children. Pediatric AIDS Clinical Trials Group Protocol 144 Study TeamR C Stevens, J H Rodman, F H Yong, et al.
AIDS (London, England)|February 1, 1997
Dependence of the hazard of AIDS on markersF H Yong, J M Taylor, J L Bryant, et al.
The Journal of Infectious Diseases|November 9, 2000
Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral therapy in infected childrenS A Spector, K Hsia, F H Yong, et al.
The Journal of Pediatrics|October 27, 1998
A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study TeamR E McKinney, G M Johnson, K Stanley, et al.
The New England Journal of Medicine|December 22, 1999
Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 TeamS E Starr, C V Fletcher, S A Spector, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Statistics in Medicine|January 30, 2004
Growth velocity assessment in paediatric AIDS: smoothing, penalized quantile regression and the definition of growth failureV J Carey, F H Yong, L M Frenkel, et al.
AIDS (London, England)|August 26, 1998
Pediatric AIDS prognosis using somatic growth velocityV J Carey, F H Yong, L M Frenkel, et al.
AIDS Research and Human Retroviruses|April 20, 2000
Effect of food and pharmacokinetic variability on didanosine systemic exposure in HIV-infected children. Pediatric AIDS Clinical Trials Group Protocol 144 Study TeamR C Stevens, J H Rodman, F H Yong, et al.
AIDS (London, England)|February 1, 1997
Dependence of the hazard of AIDS on markersF H Yong, J M Taylor, J L Bryant, et al.
The Journal of Infectious Diseases|November 9, 2000
Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral therapy in infected childrenS A Spector, K Hsia, F H Yong, et al.
The Journal of Pediatrics|October 27, 1998
A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study TeamR E McKinney, G M Johnson, K Stanley, et al.
The New England Journal of Medicine|December 22, 1999
Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 TeamS E Starr, C V Fletcher, S A Spector, et al.
Pageof 1